Curbing Exosome Communications via Introducing Artificial Membrane Receptors for Metastatic Pancreatic Cancer Therapy

Area of Science:

• Biomedical Engineering
• Cancer Biology
• Nanotechnology

Background:

• Tumor-derived exosomes (TDEs) are key mediators of cancer metastasis, facilitating intercellular communication and pre-metastatic niche (PMN) formation.
• Targeting both primary tumors and TDEs simultaneously presents a significant challenge in developing effective anti-metastatic therapies.

Purpose of the Study:

• To develop a novel two-step delivery strategy for simultaneously targeting primary tumors and TDEs.
• To inhibit tumor growth and suppress TDE-mediated metastasis in pancreatic cancer models.

Main Methods:

• Metabolic glycoengineering and bio-orthogonal click chemistry were employed to create a two-step targeting system.
• Tetraacetylated N-azidoacetyl-d-mannosamine-loaded nanoparticles tagged tumor cells and TDEs with azide groups.
• Dibenzyl-cyclooctyne-modified nanoparticles then reacted specifically with azide-tagged cells and TDEs.

Main Results:

• The strategy successfully inhibited tumor growth in pancreatic cancer models.
• It effectively curbed TDE-induced liver PMN formation and metastasis.
• The approach tracked and downregulated exosomal macrophage migration inhibitory factor (MIF).

Conclusions:

• This dual-targeting strategy offers a promising approach for suppressing pancreatic cancer metastasis.
• Interference with TDEs' communicative role and PMN induction is crucial for effective cancer therapy.